Archives

Telstra remains in focus as Australia's communications sector places greater emphasis on network resilience, dependable service quality and consistent operational execution within a selective market environment.

• July 21, 2026 10:52 AM AEST
• Sam

Qube Holdings Limited (ASX: QUB) has notified the ASX that approximately 10.8 million employee incentive plan rights have ceased to be classified as equity securities following a determination that these instruments will be cash-settled rather than equity-settled. The change arose in connection with the company's Scheme of Arrangement with Rubik Australia Pty Ltd, with the cessation effective from 13 July 2026. Of the affected rights, 633,765 have vested and will receive cash settlement upon scheme implementation, while 10.2 million remaining rights will be cash-settled if and when they vest under their contractual terms.

• July 21, 2026 10:51 AM AEST
• Sonal Goyal

Streamplay Studio remains in focus as Winter Burrow continues generating commercial momentum ahead of its planned expansion onto mobile platforms.

• July 21, 2026 10:50 AM AEST
• Sam

Biotron Limited has received formal feedback from the European Medicines Agency regarding the regulatory pathway for SedRx, its next-generation general anaesthetic candidate. The company has clarified its development strategy following EMA guidance that a Hybrid Marketing Authorisation Application pathway is not suitable under current European Union legislation. Biotron continues to progress both its anaesthetic and antiviral drug development programs while strengthening its board leadership.

• July 21, 2026 10:48 AM AEST
• Shwetambri Chauhan

REA Group, Life360 and DroneShield continue attracting market attention as investors evaluate business fundamentals and long-term growth themes across property technology, digital services and defence.

• July 21, 2026 10:48 AM AEST
• Sam

ECS Botanics remains under scrutiny as reliable cultivation, manufacturing quality, product availability, cost discipline and careful cash management shape its position within Australia’s medicinal cannabis sector today.

• July 21, 2026 10:46 AM AEST
• Sam

Australian shares are expected to open lower as geopolitical tensions support oil prices, while Telix Pharmaceuticals remains in focus after reporting higher second-quarter revenue.

• July 21, 2026 10:46 AM AEST
• Sam

Vitura faces closer scrutiny as platform governance, patient access, pharmacy execution, service consistency and cash conversion shape confidence in its regulated digital healthcare model.

• July 21, 2026 10:46 AM AEST
• Sam

Little Green Pharma is under focus as export discipline, reliable channels, regulated supply, margin quality and cash management shape its medicinal cannabis operating story in a selective Australian market.

• July 21, 2026 10:44 AM AEST
• Sam

BHP is under closer scrutiny as iron ore strength, copper delivery, portfolio balance, cost control and cash conversion shape the latest Australian resources debate.

• July 21, 2026 10:36 AM AEST
• Sam